Winzerlaer Str. 2
07745 Jena
Germany
Phone: +49 3641 579760
Fax: +49 3641 579761
http://www.zenteris.de
info@zenteris.de
Company Contacts
Department/ Name Address
Geschäftsführerin Dr. Claudia Gluch Winzerlaer Str. 2, 07745 Jena, Deutschland, Telefon: +49 3641 579760, Telefax: +49 3641 579761
info@zenteris.de
Company Figures
Number of employees 1-19
Year of foundation 2005
Area of business Laboratory Equipment
Diagnostics
Language: German Language: English Company Profile
Zenteris GmbH
About us.
Zenteris GmbH, originally JENOPTIK Instruments GmbH, was established in 2005 as a developer and manufacturer of biophotonic instruments. After having successfully developed a first generation of instruments for the detection of safety-related hazardous biological agents designed for civilian and military use, Zenteris decided to create a new corporate identity and broaden its field of expertise in order to better meet the needs of its target market.
In response to the wishes of our customers, our product portfolio was expanded to not only include the manufacture of instruments but also the manufacture of biological assays and other consumables required by our products. With its new corporate identity, Zenteris GmbH has evolved into a provider of complete solutions for the multiplex detection of safety-related hazardous biological agents with a focus on ease-of-use, capable of meeting the needs of today’s market.
Product Information
02.01 Analyser appliances
APPROVE-B® Cartridge 26.09.2008
In der APPROVE-B® Cartridge findet die biochemische Nachweisreaktion statt.
Die Vorteile der APPROVE-B® Cartridge sind:
keine Kontaminationsgefahr durch vollständig gekapselten Reaktionsraum
keine Spülschritte erforderlich
einzeln qualitätsgeprüfte Biochips
einzeln kalibrierte Halbleiterelemente zur Temperatursteuerung
Durchführung von Nukleinsäurenachweisen oder immunologischen Tests
hohe Nachweissicherheit durch interne Parallelbestimmungen und mehrere Marker pro Gefahrstoff
APPROVE-B® System. 26.09.2008
APPROVE-B® System.
With the APPROVE-B® System, Zenteris® provides the most advanced technology available today for fully-automated, parallel detection of multiple hazardous biological substances using immunological and nucleic acid-based techniques, thereby completely eliminating the need for complex and costly laboratory diagnostics. The APPROVE-B® System maximizes sensitivity, selectivity, and reliability while minimizing the amount of time required to carry out an analysis. Analysis results are presented to the user in such a way that required actions can be carried out without any special knowledge of biology.
APPROVE-B® Analysis System
The compact and durable APPROVE-B® Analysis System carries out a fully-automated analysis in 30-60 minutes.
The steps of the analysis process in detail:
Specific amplification and fluorescence labeling of sample DNA (NAT)
Hybridization of sample DNA with capture molecules, or binding of labeled detection antibody and capture antibody with the sample antigen
Image acquisition and image analysis
Display of the results
03.01.02 DNA diagnosis kits
03.01.02.01 Lab-on-a-chip
03.02.07 Immuno assay systems
03.02.07.06 Enzyme immunoassay (EIA, ELISA, EMIT)